Biocytogen funding history / development milestones

IPO上市,

2025.12.01,

IPO上市,

2022.09.01,

基石轮,4980万美元

战略投资,数千万美元

D轮,5.43亿人民币

C轮,4.1亿人民币

B轮,融资金额未公开

2017.12.28, 国投创业

A轮,融资金额未公开

2015.11.12, 高新投资

Note: collected from public online reports, for reference only.

People who follow Biocytogen also follow

Biocytogen Competitors (Similar Companies)

医药 抗体 生物医药 抗体药
“Helping partners successfully develop new drugs, reducing R&D costs an”
制药/药业 医药 生物医药 新药研发
“Health for Humanity, Creating a Better Future Together”
“一家拥有70余年辉煌历史的制药企业”
“To develop high-quality biologics that are accessible and affordable f”
生命科学 生物信息 生物制药 干细胞
医药 医药服务 CRO 临床研究
“Focused on three major fields: healthcare, life science, and electroni”
“Full-scenario immunodiagnostic technology platform”
“One of the leading enterprises in the pharmaceutical industry”
医药 生物医药 创新药 制药/药业
“Dedicated to model animals for 24 years”
“See good doctors, buy good medicine”
“Manufacturing "biochips" to provide source power for the development o”